Egyptian Drug Authority signs agreement to enhance vocational training in the medical sector
The fifth edition of the Africa Health ExCon 2026 witnessed a new step aimed at developing the health sector in Egypt. The Egyptian Drug Authority (EDA) signed a strategic cooperation protocol with GlaxoSmithKline Egypt, as part of the state's ongoing efforts to improve the level of medical and pharmaceutical services.
This protocol primarily aims to enhance professional training and development programs for workers in the pharmaceutical sector. Through this partnership, the Authority seeks to exchange scientific and technical expertise, which contributes to raising the efficiency of human resources and developing the skills necessary to keep pace with the latest global standards in the pharmaceutical industry.
This cooperation comes at a time when Egypt is seeking to strengthen its position as a regional hub for medical industries on the African continent. It is expected that this training will lead to improving the quality of pharmaceutical products available to citizens and ensuring the provision of safe and effective medicines in accordance with the highest quality standards.
This agreement is part of a broader vision adopted by the Egyptian Drug Authority to strengthen the partnership between the public and private sectors. The Authority emphasizes that investing in vocational training is the fundamental pillar for developing the health system, which is directly reflected in improving the healthcare provided to patients across the Republic.